Summary: Choosing between round and anatomical form-stable implants is a key decision in the process of breast augmentation. Anatomical devices have been subject to a number of misconceptions that have limited their use. However, in optimal clinical practice, the benefits and risks of both anatomical and round implants should be considered for any given patient. Patient and surgeon education is fundamental in ensuring that misunderstandings are addressed. The choice between anatomical and round devices should be based on a combination of patient desires, anatomy, and surgical history. This report presents experience-based recommendations on indications and contraindications for each type, and a proposed algorithm for decision making in clinical practice.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, V.
Stockholm, Sweden; Dallas, Texas; Heidelberg, Germany; Tel Aviv, Israel; Loma Linda, Calif.; and Nashville, Tenn.
From the Akademikliniken; University of Texas Southwestern Medical Center; Ethianum Clinic and Heidelberg University; private practice; Loma Linda School of Medicine; and Vanderbilt University.
Received for publication October 29, 2014; accepted February 10, 2015.
Disclosure: Dr. Hedén is a consultant and speaker for Allergan, Inc. (Irvine, Calif.) and an unpaid consultant for Canfield Scientific (Fairfield, N.J.). Dr. Montemurro is a consultant and speaker for Allergan, Inc. Dr. Adams is an educational consultant for Allergan; an unpaid consultant for Canfield Scientific; a royalty recipient from McGraw Hill (New York, N.Y.); a research grant recipient for shaped-implant FDA IDE clinical trials; and founder of The Plastic Surgery Channel. Dr. Germann is a consultant and speaker for Allergan, Inc. Dr. Scheflan is a consultant and speaker for Allergan, Inc., Canfield Scientific, and TEI Bioscience (Boston, Mass.). Dr. Maxwell is a consultant and royalty recipient for Allergan, Inc; a consultant for LifeCell Corporation (Branchburg, N.J.); and a consultant and stockholder for The GID Group (Louisville, Colo.).
Per Hedén, M.D., Ph.D., Akademikliniken, Storängsvägen 10, 115 42 Stockholm, Sweden, email@example.com